Rapid Result

Prostate Specific Antigen (PSA) Rapid Test

Quick, reliable prostate cancer screening with results in minutes.

CE Certified
ISO 13485
Main image of Prostate Specific Antigen (PSA) Rapid Test

Why Choose reOpenTest Oncology Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Rapid Results

Get preliminary screening results in just 10 minutes, enabling faster clinical decisions.

Simple Sample

Requires only a small serum or plasma sample, minimizing patient discomfort.

User-Friendly

Easy-to-use immunochromatographic technology for clear and reliable results.

Product Overview

The Prostate Specific Antigen (PSA) Rapid Test is a point-of-care test for the rapid detection of elevated PSA levels in serum or plasma. It provides a preliminary screening result for prostate cancer, which should be confirmed by further clinical evaluation. Elevated PSA levels can indicate prostate cancer or other conditions like BPH. Use with caution and interpret in conjunction with other clinical findings.

Technical Specifications

Detection Target Prostate Specific Antigen (PSA)
Sample Type Serum or Plasma
Methodology Immunochromatography
Detection Range Qualitative: Positive/Negative (above or below a pre-defined cut-off)
Reaction Time 10 minutes
Storage Conditions 2-30u00b0C
Shelf Life 18 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect serum or plasma sample.
  2. Apply sample to the test device.
  3. Wait 10 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: A colored band in the test region indicates a PSA level above the cutoff, suggesting potential prostate issues.
Negative Result
Negative: Absence of a colored band in the test region indicates a PSA level below the cutoff.
Invalid Result
Invalid: If the control band does not appear, the test is invalid and should be repeated.

Frequently Asked Questions

A positive result suggests an elevated PSA level, which could indicate prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. Further clinical evaluation is needed to confirm the diagnosis.

The PSA rapid test is designed for preliminary screening and may have different sensitivity and specificity compared to lab-based tests. Confirm all positive results with a lab-based assay.

While this test can provide a quick indication of PSA levels, lab-based tests are recommended for precise monitoring of PSA levels during treatment.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor